John Hamer, Director at AbCellera Biologics Inc. (ABCL), sold 600,000 shares at $16.93 ($10.2M) on 2021-09-01, disclosed to the SEC on 2021-09-02.
Open-market sale of $10.2M ABCL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.95 | 162,649 | $2.8M | 27.1% |
| 2 | $16.95 | 162,649 | $2.8M | 27.1% |
| 3 | $16.93 | 137,351 | $2.3M | 22.9% |
| 4 | $16.93 | 137,351 | $2.3M | 22.9% |
| Total | $16.94 avg | 600,000 | $10.2M | 100% |